← FDA Drug Approvals (Drugs@FDA)

CARMUSTINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2018-10-16

Drug application

FDA Application #
ANDA211229
Application type
Abbreviated New Drug Application (Generic)
Brand name
CARMUSTINE
Generic name
CARMUSTINE
Active ingredients
CARMUSTINE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AMNEAL
Manufacturer
Amneal Pharmaceuticals LLC
First approval
2018-10-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown